In 2019, join The Scientist to explore a myriad of contemporary research questions. From precision medicine to biomarker discov-
ery in immuno-oncology, the human microbiome to rare genetic disease, and -omics in neurological disease to stem cell research
for in vitro modeling, learn from scientists at the forefront of life science research topics and techniques.
For further information about our free educational and informative webinars, visit http://www.the-scientist.com/sponsored-webinars.
Check back frequently, because new topics are added each month!
What’s leading to the biomarker bottleneck in oncology, and what can be done about it? Join us to learn more.
How will genomics, proteomics, metabolomics, and other -omics contribute to our understanding of neurological disease and dysfunction?
ALICE O. KAMPHORST, PhD
Assistant Professor
Department of Oncological Sciences
Precision Immunology Institute
Icahn School of Medicine at Mount SinaiNICHOLAS SEYFRIED, PhD
Associate Professor
Depts. of Biochemistry and Neurology
Emory School of MedicineThe Biomarker Bottleneck in Immuno-oncology:
Understanding to Overcome-Omics Analysis for
Brain DisordersCOMINGSOON
COMINGSOON
WEDNESDAY, JANUARY 23
2:30-4:00 PM EASTERN TIMEWEDNESDAY, FEBRUARY 27
2:30-4:00 PM EASTERN TIMEREGISTER NOW!
http://www.the-scientist.com/biomarkerbottleneck-webinar
The webinar video will also be available at this link.REGISTER NOW!
http://www.the-scientist.com/omicsforthebrain-webinar
The webinar video will also be available at this link.
EUGENIA TRUSHINA, PhD
Associate Professor
Depts. of Neurology and Pharmacology,
Director, Mitochondrial Neurobiology
and Therapeutics Laboratory
Mayo ClinicTOPICS TO BE COVERED:- Assessing heterogeneity of immune
cell infiltration in tumors to predict
response to cancer immunotherapy
TOPICS TO BE COVERED:- Integrative proteomics for novel target and
biomarker discovery in Alzheimer’s Disease - The application of metabolomics for biomarker
discovery in Alzheimer’s Disease
Rapid Molecular Diagnostic Tests for Infectious Diseases
Precision Medicine in Oncology: No Two Tumors Alike
Challenges Facing the Precision Medicine Initiative: Going Global
The Human Microbiome: Beyond the Gut
Stem Cells for In Vitro Modeling of Neurological Disease
Rare Genetic Disease: Models and Mechanisms
Overcoming Off-target Effects in CRISPR-Cas9 Genome Editing: Securing SpecificityCOMINGSOON